Evidence for novel non-angiogenic pathway in breast-cancer metastasis

F. Pezzella; M. Manzotti; A. Di Bacco; G. Viale; A. G. Nicholson; R. Price; C. Ratcliffe; U. Pastorino; K. C. Gatter; A. L. Harris; D. G. Altman; S. Pilotti; U. Veronesi

Evidence for novel non-angiogenic pathway in breast-cancer metastasis

F. Pezzella, M. Manzotti, A. Di Bacco, G. Viale, A. G. Nicholson, R. Price, C. Ratcliffe, U. Pastorino, K. C. Gatter, A. L. Harris, D. G. Altman, S. Pilotti, U. Veronesi

Research output: Contribution to journal › Article › peer-review

Abstract

We have reported that angiogenic primary breast carcinoma can relapse not only as angiogenic, but also as non-angiogenic, lung metastases. This non-angiogenic pathway seems to be a novel pathway of cancer progression, and such tumours are likely to be resistant to antiangiogenic treatment.

Original language	English
Pages (from-to)	1787-1788
Number of pages	2
Journal	Lancet
Volume	355
Issue number	9217
Publication status	Published - May 20 2000

ASJC Scopus subject areas

Medicine(all)

Cite this

Evidence for novel non-angiogenic pathway in breast-cancer metastasis. / Pezzella, F.; Manzotti, M.; Di Bacco, A.; Viale, G.; Nicholson, A. G.; Price, R.; Ratcliffe, C.; Pastorino, U.; Gatter, K. C.; Harris, A. L.; Altman, D. G.; Pilotti, S.; Veronesi, U.

In: Lancet, Vol. 355, No. 9217, 20.05.2000, p. 1787-1788.

Research output: Contribution to journal › Article › peer-review

@article{c4d2c1afa12e4ca6826d8b3a40a0979c,

title = "Evidence for novel non-angiogenic pathway in breast-cancer metastasis",

abstract = "We have reported that angiogenic primary breast carcinoma can relapse not only as angiogenic, but also as non-angiogenic, lung metastases. This non-angiogenic pathway seems to be a novel pathway of cancer progression, and such tumours are likely to be resistant to antiangiogenic treatment.",

author = "F. Pezzella and M. Manzotti and {Di Bacco}, A. and G. Viale and Nicholson, {A. G.} and R. Price and C. Ratcliffe and U. Pastorino and Gatter, {K. C.} and Harris, {A. L.} and Altman, {D. G.} and S. Pilotti and U. Veronesi",

year = "2000",

month = may,

day = "20",

language = "English",

volume = "355",

pages = "1787--1788",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Lancet Publishing Group",

number = "9217",

}

TY - JOUR

T1 - Evidence for novel non-angiogenic pathway in breast-cancer metastasis

AU - Pezzella, F.

AU - Manzotti, M.

AU - Di Bacco, A.

AU - Viale, G.

AU - Nicholson, A. G.

AU - Price, R.

AU - Ratcliffe, C.

AU - Pastorino, U.

AU - Gatter, K. C.

AU - Harris, A. L.

AU - Altman, D. G.

AU - Pilotti, S.

AU - Veronesi, U.

PY - 2000/5/20

Y1 - 2000/5/20

N2 - We have reported that angiogenic primary breast carcinoma can relapse not only as angiogenic, but also as non-angiogenic, lung metastases. This non-angiogenic pathway seems to be a novel pathway of cancer progression, and such tumours are likely to be resistant to antiangiogenic treatment.

AB - We have reported that angiogenic primary breast carcinoma can relapse not only as angiogenic, but also as non-angiogenic, lung metastases. This non-angiogenic pathway seems to be a novel pathway of cancer progression, and such tumours are likely to be resistant to antiangiogenic treatment.

UR - http://www.scopus.com/inward/record.url?scp=0034690655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034690655&partnerID=8YFLogxK

M3 - Article

C2 - 10832831

AN - SCOPUS:0034690655

VL - 355

SP - 1787

EP - 1788

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9217

ER -

Evidence for novel non-angiogenic pathway in breast-cancer metastasis

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this